Impact of regulatory system changes on the availability of innovative drugs in China
Qianwei Ge, Lili Xu, Joseph A. DiMasi, Kenneth I. Kaitin, Liming Shao
Topics & Concepts
ChinaBusinessDrug approvalRisk analysis (engineering)Drug developmentPharmacologyDrugMedicinePolitical scienceLawBiotechnology and Related FieldsPharmaceutical Economics and PolicyScience, Research, and Medicine